Kaja Abbas 准教授
専門・研究テーマ・キーワード
ワクチン効果モデリング担当課程
博士前期課程専任教員博士後期課程専任教員取得学位・資格
PhD
個人/所属ウェブページ
連絡先
他所属
School of Tropical Medicine and Global Health, Nagasaki University London School of Hygiene and Tropical Medicine
経歴
My research area is vaccine impact modelling with a focus on estimating the health, economic, and equity impact of vaccination programmes to support evidence-based decision-making on vaccination strategies in collaboration with partners and stakeholders at the global, regional, and national levels. I have worked on impact assessment of existing and new vaccines to inform vaccine policy in varied contextual settings of low-, middle-, and high-income countries. I hold a joint position with LSHTM and Nagasaki University. I welcome collaborations related to estimating vaccination impact in different geographic settings, and you are welcome to contact me.
教育活動
- Epidemiology and Statistics for Population Health
- Advanced Methods of Policy Analysis
- Global Health Seminar
研究活動
- Vaccine impact modelling
- Vaccine epidemiology and economics
現在の主な研究活動地域
Global
最近の5つの出版物
- Kim S, Kang H, Skrip L, Sahastrabuddhe S, Islam A, Jung SM, Vesga JF, Endo A, Edmunds WJ, Abbas K. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response. Expert Rev Vaccines. 2025; 24(1):183-193.
- Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. Lancet Infect Dis. 2024; 24(5):488-503.
- Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Gopal Dhoubhadel B, John Edmunds W, Clark A, Abbas K. Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health. 2024; 2(2):e001089.
- Abbas K, Yoo KJ, Prem K, Jit M. Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. EclinicalMedicine. 2024; 70:102524.
- Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Glob Health. 2023; 8(7):e011341.
-
More publications can be viewed on the ResearchMap and LSHTM page